Search by Drug Name or NDC
NDC 57844-0019-01 Adipex-P 37.5 mg/1 Details
Adipex-P 37.5 mg/1
Adipex-P is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is PHENTERMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Phentermine is used for a limited period of time to speed weight loss in overweight people who are exercising and eating a low-calorie diet. Phentermine is in a class of medications called anorectics. It works by decreasing appetite.
Related Packages: 57844-0019-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Phentermine
Product Information
| NDC | 57844-0019 |
|---|---|
| Product ID | 57844-019_305baa45-88c4-4a2c-9086-2ddafc27cf9d |
| Associated GPIs | 61200070100120 |
| GCN Sequence Number | 005155 |
| GCN Sequence Number Description | phentermine HCl CAPSULE 37.5 MG ORAL |
| HIC3 | J8A |
| HIC3 Description | ANTI-OBESITY - ANOREXIC AGENTS |
| GCN | 20693 |
| HICL Sequence Number | 002111 |
| HICL Sequence Number Description | PHENTERMINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Adipex-P |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Phentermine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 37.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENTERMINE HYDROCHLORIDE |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Pharmaceutical Class | Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA088023 |
| Listing Certified Through | n/a |
Package
NDC 57844-0019-01 (57844001901)
| NDC Package Code | 57844-019-01 |
|---|---|
| Billing NDC | 57844001901 |
| Package | 100 CAPSULE in 1 BOTTLE (57844-019-01) |
| Marketing Start Date | 1990-09-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |